- BioSpecifics Technologies (NASDAQ:BSTC) Q2 results: $2.7M (-18.9%); Operating Income: $0.9M (-44.0%); Net Income: $0.6M (-43.8%); EPS: $0.08 (-46.7%); Quick Assets: $16.6M (+31.7%).
- No financial guidance given.
More on BioSpecifics Tech Q2 results
Recommended For You
More Trending News
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BSTC | - | - |
| BioSpecifics Technologies Corp. | ||